Two new series of cyclometalated iridium(III) complexes bearing a dipyridylamine as the N^N ligand have been prepared and fully characterized. After investigation of their photophysical properties, their catalytic activities have been evaluated in a model photoredox reaction and compared with the commercially available [Ir(ppy)2(dtbbpy)][PF6] complex.
No takes yet. Share an insight, caveat, or question.
Sauvageot et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: